Discussion In this study, the genotype-guided group exhibited a lower risk of MACCEs compared with the SoC group, although this difference did not reach statistical significance (8.7% vs 10.7%, HR=0.56, p=0.27).
← all excerpts
Implementing a pharmacogenomic-driven algorithm to guide antiplatelet therapy among Caribbean Hispanics: a non-randomised clinical trial.
1
0.2700
0.2700